Clinical and Pathological Features and the BRAFV600E Mutation in Patients with Papillary Thyroid Carcinoma with and without Concurrent Hashimoto Thyroiditis-Reference-Cited by-同舟云学术

Clinical and Pathological Features and the BRAFV600E Mutation in Patients with Papillary Thyroid Carcinoma with and without Concurrent Hashimoto Thyroiditis

Published:2009-02 Issue:2 Volume:19 Page:137-141
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Kim Suk Kyeong¹,Song Kee-Ho¹,Lim So Duk²,Lim Young Chang³,Yoo Young Bum⁴,Kim Ji Soo⁵,Hwang Tae Sook²

Affiliation:

1. Department of Internal Medicine, Konkuk University School of Medicine, Konkuk University Medical Center, Seoul, Korea.

2. Department of Pathology, Konkuk University School of Medicine, Konkuk University Medical Center, Seoul, Korea.

3. Department of Otorhinolaryngology–Head and Neck Surgery, Konkuk University School of Medicine, Konkuk University Medical Center, Seoul, Korea.

4. Department of Surgery, Konkuk University School of Medicine, Konkuk University Medical Center, Seoul, Korea.

5. Department of Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2008.0144

Reference23 articles.

1. Expression of theRET/PTCFusion Gene as a Marker for Papillary Carcinoma in Hashimoto's Thyroiditis

2. Expression of p63 in papillary thyroid carcinoma and in Hashimoto’s thyroiditis: a pathobiologic link?

3. The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Association between Lymphocytic Thyroiditis and Papillary Thyroid Cancer Harboring Mutant BRAF: A Systematic Review and Meta-Analysis;Thyroid®;2024-07-18

2. Clinical impact of coexistent chronic lymphocytic thyroiditis on central lymph node metastasis in low- to intermediate-risk papillary thyroid carcinoma: The MASTER study;Surgery;2024-04

3. Prevalence and Impact of BRAF mutation in patients with concomitant papillary thyroid carcinoma and Hashimoto’s thyroiditis: a systematic review with meta-analysis;Frontiers in Endocrinology;2023-11-17

4. Hashimoto’s Thyroiditis: A Protective Factor against Recurrence in BRAF-Wild Type Differentiated Thyroid Carcinoma;Cancers;2023-04-19

5. Papillary Thyroid Carcinoma: A Narrative Review on the Most Important Genetic and Epigenetic Alterations;Current Pharmacogenomics and Personalized Medicine;2023-04